510(k) Report

510(k) · Cleared

Cleared

hyperion X9 pro, NewTom GiANO HR, X-RADiUS TRiO PLUS

K214084510(k) SpecialCleared Jan 20, 202224-day reviewClass II21 CFR 892.1750

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Cefla S.C. · OAS X-Ray, Tomography, Computed, Dental

Cleared on Jan 20, 2022 as substantially equivalent to K190496 (Cefla S.C., 2019) after a 24-day review. Its family tree reaches back 1 generation to 2019. 1 later device descends from it.

Decided
Jan 20, 2022
Review
24 days
Class
Class II
Product code
OAS
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K190496 (2019). 1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2023: 1 descendant clearedK190496 · hyperion X9 pro, NewTom GiANO HR, X-RADiUS TRiO PLUS · Cefla S.C. · 2019201620182020202220242026
Descendants, by generation 1 generation forward: 1 descendant K190496 · hyperion X9 pro, NewTom GiANO HR, X-RADiUS TRiO PLUS · Cefla S.C. · 20190
  1. Root · 1 generation backK190496 hyperion X9 pro, NewTom GiANO HR, X-RADiUS TRiO PLUSCefla S.C. · 2019
  2. This deviceK214084 hyperion X9 pro, NewTom GiANO HR, X-RADiUS TRiO PLUSCefla S.C. · 2022
  3. Descendant · cites it directly · 0 of its ownK223794 hyperion X9 pro, NewTom GiANO HR, X-RADiUS TRiO PLUSCefla S.C. · 2023

Most influential descendants

Showing 1 of 1 · See all
  • K223794hyperion X9 pro, NewTom GiANO HR, X-RADiUS TRiO PLUSCefla S.C. · 2023 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K190496hyperion X9 pro, NewTom GiANO HR, X-RADiUS TRiO PLUSCefla S.C.2019—
0 (this device)K214084hyperion X9 pro, NewTom GiANO HR, X-RADiUS TRiO PLUSCefla S.C.2022—
+1K223794hyperion X9 pro, NewTom GiANO HR, X-RADiUS TRiO PLUSCefla S.C.2023—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202310
FIG. 1 — Lineage of K214084, 2019–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OAS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OAS device

  1. #1 K213226 RCT700score 18.0 · 13 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K190496hyperion X9 pro, NewTom GiANO HR, X-RADiUS TRiO PLUS
Summary page 4
…omographic radiological system developed and manufactured by CEFLA S.C. The proposed device is a change of the predicate device: hyperion X9 pro (K190496). Like the predicate device the proposed device can be sold under three different proprietary product nam…
Cefla S.C.2019—

Also cleared against K190496: 1 other device →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K223794hyperion X9 pro, NewTom GiANO HR, X-RADiUS TRiO PLUSCefla S.C.20230

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K223794 (Cefla S.C., 2023) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K190496.

How does its category compare?

All OAS devices

OAS X-Ray, Tomography, Computed, Dental: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · OAS

9in 2025

2007: 22008: 22009: 22010: 12011: 62012: 72013: 102014: 52015: 52016: 122017: 42018: 112019: 72020: 92021: 112022: 62023: 122024: 42025: 92026 (partial year): 9
2007high 12 (2016) · low 1 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OAS

144in 2025

2011: 168 days median2012: 110 days median2013: 155 days median2014: 170 days median2015: 164 days median2016: 154 days median2017: 209 days median2018: 57 days median2019: 55 days median2020: 113 days median2021: 92 days median2022: 105 days median2023: 77 days median2024: 129 days median2025: 144 days median2026 (partial year): 77 days median
2007high 209 (2017) · low 55 (2019)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · OAS

3in 2025

2015: 12025: 3
2007high 3 (2025) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · OAS

1in 2025

2008: 12019: 12022: 12023: 12024: 22025: 1
2007high 2 (2024) · low 0 (2007)2025

MAUDE reports naming product code OAS, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20082—01
20092—00
20101—00
2011616800
2012711000
20131015500
2014517000
2015516410
20161215400
2017420900
2018115700
201975501
2020911300
2021119200
2022610501
2023127701
2024412902
2025914431
20269770—

What is it indicated for?

hyperion X9 pro, NewTom GiANO HR, X-RADiUS TRiO PLUS is digital panoramic, cephalometric and tomographic extra-oral system, intended to: () produce orthopanoramic images of the maxillofacial region and carry out diagnostic examination on teeth, dental arches and other structures in the oral cavity; (II) produce radiographs of jaws, parts of the skull and carpus for the purpose of cephalometric examination, if equipped with tele-radiographic arm (CEPH)…

Read the full statement (134 words)

hyperion X9 pro, NewTom GiANO HR, X-RADiUS TRiO PLUS is digital panoramic, cephalometric and tomographic extra-oral system, intended to:

() produce orthopanoramic images of the maxillofacial region and carry out diagnostic examination on teeth, dental arches and other structures in the oral cavity;

(II) produce radiographs of jaws, parts of the skull and carpus for the purpose of cephalometric examination, if equipped with tele-radiographic arm (CEPH);

(II1) the production of tomographic images of the head, including the ear, nose and throat (ENT), of the dento-maxillofacial complex, teeth, mandible and maxilla, temporomandibular-articular joint (TMJ), other areas of the human skull and neck with sections of the cervical spine for use in diagnostic support, if equipped with the CBCT option.

The device is operated and used by physicians, dentists, x-ray technologists and other legally qualified professionals.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K214084: hyperion X9 pro, NewTom GiANO HR, X-RADiUS TRiO PLUS.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K214084

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026